Guobang Pharma Ltd. (605507)

Overview

Guobang Pharma Ltd. is a prominent entity in the pharmaceutical and veterinary industries, specializing in the research, development, production, and sale of a wide range of products. Since its establishment in 1996, the company has positioned itself as a major player in the global market, offering its products in approximately 112 countries and regions. Based in Xinchang, China, Guobang Pharma Ltd. dedicates itself to providing high-quality healthcare solutions, adhering to the pursuit of innovation and excellence in its field.

Products and Services

Quinolones: A category of antibacterial agents that Guobang Pharma Ltd. produces, known for their efficacy in treating a wide range of bacterial infections by inhibiting bacterial DNA replication.

Marcolides: Another critical group of antibiotics, focusing on the treatment of various bacterial infections by inhibiting protein synthesis within bacterial cells, thus preventing their growth and proliferation.

Cephalosporins: Broad-spectrum antibiotics produced by Guobang Pharma Ltd. that are used to combat a wide variety of bacterial infections. These compounds work by disrupting the synthesis of the peptidoglycan layer of bacterial cell walls, leading to cell death.

Characteristic APIs: Active Pharmaceutical Ingredients (APIs) that are distinctive to Guobang Pharma Ltd., showcasing the company’s capacity to deliver high-quality, potent ingredients for the formulation of various medications.

Preparations and Accessories: This encompasses a range of formulated products and necessary auxiliary components that cater to diverse healthcare needs, ensuring that medications are delivered in the most effective and patient-friendly manner.

Key Pharmaceutical Intermediates: Essential compounds in the production of pharmaceutical products, these intermediates are pivotal for the synthesis of a wide array of active pharmaceutical ingredients, underpinning the company’s product development processes.

Mobile Protection APIs: These innovative APIs are designed to counteract the effects of mobile pathogens, offering solutions to combat mobile bacterial infections effectively.

Kinetophoretic Preparations: Preparations that leverage the principles of kinetophoresis for drug delivery, enhancing the effectiveness and efficiency of therapeutic interventions.

Feed Additives: A range of products offered by Guobang Pharma Ltd. aimed at enhancing the nutritional value of animal feed, thereby supporting the health and growth of livestock in the veterinary sector.